Catalyst Wire Dossier Catalyst Wire Dossier

Human Rabies Immunoglobulin

human rabies immunoglobulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Rabies Immunoglobulin, covering 2017-04-07 to 2017-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age [Phase 3]

See pricing